Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

BACKGROUND: Knowledge of possible cardiovascular risks from Parkinson's disease (PD) medications is critical to informing safe and effective treatment decisions. The objective of our study was to determine whether PD patients treated with nonergot dopamine agonists (DAs) are at increased risk o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mov Disord Clin Pract
Auteurs principaux: Crispo, James A.G., Willis, Allison W., Thibault, Dylan P., Fortin, Yannick, Emons, Matthew, Bjerre, Lise M., Kohen, Dafna E., Perez‐Lloret, Santiago, Mattison, Donald, Krewski, Daniel
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2015
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178630/
https://ncbi.nlm.nih.gov/pubmed/30363519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12286
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires